Barclays’s Innovator US Equity Accelerated Plus ETF January XTJA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-171
Closed -$5.21K 5679
2026
Q1
$5.21K Sell
171
-1,745
-91% -$55K ﹤0.01% 4770
2025
Q4
$60.6K Sell
1,916
-2,892
-60% -$90.2K ﹤0.01% 4705
2025
Q3
$148K Sell
4,808
-257
-5% -$7.74K ﹤0.01% 4478
2025
Q2
$149K Buy
5,065
+3,414
+207% +$93.3K ﹤0.01% 4428
2025
Q1
$44.4K Buy
1,651
+284
+21% +$7.91K ﹤0.01% 4646
2024
Q4
$38K Buy
1,367
+917
+204% +$25.2K ﹤0.01% 4814
2024
Q3
$12.2K Buy
+450
New +$12K ﹤0.01% 4953

Other funds holding XTJA

Barclays's XTJA Position: Q2 2026 in Review

Barclays sold out of Innovator US Equity Accelerated Plus ETF January (XTJA) in Q2 2026, closing a stake of 171 shares — an estimated $5.21K sold.

Barclays first reported a position in XTJA in Q3 2024 and held it in 7 quarters. The position peaked at $149K in Q2 2025. 19 funds tracked by Wall St. Rank hold XTJA as of Q2 2026.

  • Barclays reported no remaining Innovator US Equity Accelerated Plus ETF January position as of Q2 2026 after selling out during the quarter.
  • Barclays sold 171 Innovator US Equity Accelerated Plus ETF January shares in Q2 2026, an estimated $5.21K.
  • Barclays first reported a position in Innovator US Equity Accelerated Plus ETF January in Q3 2024 and held it in 7 quarters.
  • Barclays's Innovator US Equity Accelerated Plus ETF January position peaked at $149K in Q2 2025.
  • 19 funds tracked by Wall St. Rank held Innovator US Equity Accelerated Plus ETF January as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.